BioSpace14h
Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...
India Infoline54m
Hetero Partners with Gilead to Expand Global Access to HIV Drug Lenacapavir
The collaboration supports efforts for HIV prevention through PrEP, emphasizing Hetero’s commitment to improving HIV care.
FiercePharma1d
Gilead strikes licensing deals with 6 generics makers to boost access to long-acting HIV PrEP med
Gilead Sciences is wasting no time in promoting worldwide access to its twice-yearly pre-exposure prophylaxis (PrEP) HIV ...
Republican-American8h
Takeaways from AP’s report on declining condom use
Condom usage is down for everyone in the U.S., but researchers say the trend is especially stark among teens and young adults ...
health.wusf.usf.edu56m
Condoms aren’t a fact of life for young Americans. They’re an afterthought
Fewer young people are having sex, but the teens and young adults who are sexually active aren't using condoms as regularly, ...
Takeaways from AP's report on declining condom use among younger generations
Condom usage is down for everyone in the U.S., but researchers say the trend is especially stark among teens and young adults ...
HIV prevention: why a new injectable drug could be such a breakthrough – podcast
HIV expert Linda-Gail Bekker talks to The Conversation Weekly about promising results from a trial of a new drug for HIV ...
STAT1d
Gilead strikes voluntary licensing deals in poor countries for its pricey HIV drug
Gilead will license the HIV drug lenacapavir, a twice-yearly injectable, to six generic makers for 120 countries.
STAT15h
Dockworker strike puts drug supplies at risk
How supplies of GLP-1 drugs could be at risk as a result of the dockworker strike occurring across the East and Gulf coasts: ...
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
The drugmaker Gilead Sciences on Wednesday announced a plan to allow six generic pharmaceutical companies in Asia and North ...
Report Finds Widespread Decline in Use of Condoms
A new report finds there is a decline in condom usage because of access to other contraceptives and drugs that prevent STIs.
MedPage Today6d
COVID Preventive Drug Should Work Against Circulating Variants, FDA Now Says
The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against currently ...